Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: ACP-196 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating ACP-196 alone and with pembrolizumab in metastatic pancreatic cancer has completed and results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: Improving Goals of Care Discussion in Advanced Cancer Patients [NA]
Clinical trial update reporting completion and results posting for a study focused on improving goals of care discussions in advanced cancer…
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating proton therapy with FOLFIRINOX and losartan for pancreatic cancer; results status not provided.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating the combination of irreversible electroporation and NK cell immunotherapy in advanced pancreatic cancer has com…
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: A Safety and Efficacy Study of RX-0201 Plus Gemcitabine in Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating RX-0201 in combination with gemcitabine for metastatic pancreatic cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: High-activity Natural Killer Immunotherapy for Small Metastases of Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 trial update of high-activity natural killer cell immunotherapy for small metastases in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-08-30Clinical Trial Update: Open Label Immunotherapy Trial of Inoperable Pancreatic Cancer [Phase 1, Phase 2]
An open-label immunotherapy trial for inoperable pancreatic cancer is underway (Phase 1/Phase 2). Current status is unknown.
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Nab-paclitaxel and Gemcitabine, in Elderly Patients Untreated Metastatic Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial evaluating nab-paclitaxel and gemcitabine in elderly patients with untreated metastatic pancreatic adenocarcinoma has complete…
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2 (HER2) Overexpressing Solid Tumors [Phase 2]
Phase 2 trial updating on trastuzumab emtansine in HER2-overexpressing solid tumors has completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Phase 2, Nab Paclitaxel/Gemcitabine Alone and in Combination With ACP-196 in Subjects With Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial of Nab Paclitaxel/Gemcitabine alone and with ACP-196 in metastatic pancreatic cancer was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-25Clinical Trial Update: Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic Cancer [Phase 3]
A Phase 3 trial evaluating adjuvant versus neoadjuvant plus adjuvant chemotherapy in resectable pancreatic cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2019-07-25Clinical Trial Update: Safety and Efficacy of Clopidogrel in Locally Advanced and Metastatic Pancreatic Adenocarcinoma Treated With Chemotherapy [Phase 3]
Phase 3 trial update on safety and efficacy of clopidogrel in locally advanced and metastatic pancreatic adenocarcinoma treated with chemoth…
-
CLINICAL_TRIALS trial_result · 2019-07-19Clinical Trial Update: A Study of Regorafenib in Advanced Pancreatic Cancer Patients [Phase 2]
Phase 2 clinical trial update of regorafenib in advanced pancreatic cancer; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2019-07-18Clinical Trial Update: Phase I of SGM-101 in Patients With Cancer of the Colon, Rectum or Pancreas [Phase 1, Phase 2]
Phase I/II clinical trial update for SGM-101 in colon, rectal, and pancreatic cancers, currently completed.
-
CLINICAL_TRIALS trial_result · 2019-07-18Clinical Trial Update: Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
A safety study of itacitinib in combination with gemcitabine and nab-paclitaxel in advanced solid tumors completed Phase 1/2.
-
CLINICAL_TRIALS trial_result · 2019-07-10Clinical Trial Update: Gemcitabine and CT-011 for Resected Pancreatic Cancer [Phase 2]
Phase 2 trial update for gemcitabine with CT-011 in resected pancreatic cancer was terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-08Clinical Trial Update: Study of Gemcitabine Plus Nab-paclitaxel Versus S1 Plus Nab-paclitaxel in Metastatic Adenocarcinoma of the Pancreas [Phase 2]
Phase 2 randomized trial comparing gemcitabine plus nab-paclitaxel versus S-1 plus nab-paclitaxel in metastatic pancreatic adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2019-06-14Clinical Trial Update: Rapid Gastric and Pancreas Cancer Staging Utilizing Peritoneal Lavage [Phase 2]
Phase 2 trial reporting results for rapid staging of gastric and pancreatic cancers using peritoneal lavage.
-
CLINICAL_TRIALS trial_result · 2019-06-13Clinical Trial Update: Phase II Study of 5-FU, Oxaliplatin Plus Dasatinib in Metastatic Pancreatic Adenocarcinoma [Phase 2]
Phase II study of 5-FU, oxaliplatin plus dasatinib in metastatic pancreatic adenocarcinoma completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-06-05Clinical Trial Update: Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery [Phase 2]
A Phase 2 clinical trial evaluating vaccine therapy with or without cyclophosphamide in pancreatic cancer patients undergoing chemoradiation…
-
CLINICAL_TRIALS trial_result · 2019-05-30Clinical Trial Update: Phase II Trial of Erlotinib in Advanced Pancreatic Cancer [Phase 2]
Phase II trial results for Erlotinib in advanced pancreatic cancer have been completed.
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDA [Phase 1, Phase 2]
Clinical trial update for nab-paclitaxel + cisplatin + gemcitabine in previously untreated metastatic pancreatic ductal adenocarcinoma (stag…
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer [Phase 3]
Phase 3 trial evaluating gemcitabine with or without capecitabine in advanced pancreatic cancer has completed.
-
CLINICAL_TRIALS research · 2019-05-08Clinical Trial Update: Clinical Research of ROBO1 Specific BiCAR-NK Cells on Patients With Pancreatic Cancer [Phase 1, Phase 2]
A clinical trial update regarding ROBO1-specific BiCAR-NK cells for pancreatic cancer in Phase 1/2.
-
CLINICAL_TRIALS trial_result · 2019-05-07Clinical Trial Update: Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC [Phase 2]
Phase 2 trial evaluating PEGPH20 in combination with pembrolizumab for second-line treatment of metastatic pancreatic ductal adenocarcinoma.